WO2016115048A1 - Production de compositions à base de rhamnolipides - Google Patents

Production de compositions à base de rhamnolipides Download PDF

Info

Publication number
WO2016115048A1
WO2016115048A1 PCT/US2016/012901 US2016012901W WO2016115048A1 WO 2016115048 A1 WO2016115048 A1 WO 2016115048A1 US 2016012901 W US2016012901 W US 2016012901W WO 2016115048 A1 WO2016115048 A1 WO 2016115048A1
Authority
WO
WIPO (PCT)
Prior art keywords
medium
rhamnolipids
composition
solid
sterilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2016/012901
Other languages
English (en)
Other versions
WO2016115048A8 (fr
Inventor
Nattaporn Lohitharn
Daniel DERR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Logos Technologies LLC
Original Assignee
Logos Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Logos Technologies LLC filed Critical Logos Technologies LLC
Priority to CN202110544567.5A priority Critical patent/CN113368777B/zh
Priority to HK18106777.6A priority patent/HK1247249A1/zh
Priority to KR1020177021080A priority patent/KR102557083B1/ko
Priority to CN201680014963.4A priority patent/CN107406867B/zh
Priority to EP16737680.5A priority patent/EP3245293B1/fr
Priority to JP2017555441A priority patent/JP6866301B2/ja
Priority to CA2973183A priority patent/CA2973183C/fr
Priority to MX2017009126A priority patent/MX2017009126A/es
Priority to AU2016207008A priority patent/AU2016207008B2/en
Priority to BR112017014710-6A priority patent/BR112017014710B1/pt
Publication of WO2016115048A1 publication Critical patent/WO2016115048A1/fr
Publication of WO2016115048A8 publication Critical patent/WO2016115048A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Definitions

  • composition comprising rhamnolipids as well as said compositions.
  • Rhamnolipids are interface-active glycolipids produced by various bacterial species. RLs consist of one (monorhamnosylipids or mono-rhamnolipids) or two rhamnose units (dirhamnosylipids or di-rhamnolipids) and one or two
  • Rhamnolipids have particular surface-active properties such as, for example, a strong foaming ability, and are of interest for highly diverse technical applications, particularly as surfactants (reviewed in Randhawa et al. (2014) "Rhamnolipid biosurfactants— past, present, and future scenario of global market", Frontiers in Microbiology 5:1-7; Muller et al. (2012)
  • potential applications include: (1) bioremediation and enhanced oil recovery(EOR) since they efficiently remove crude oil and heavy metals from contaminated soil and facilitate bioremediation of oil spills due to their emulsification properties; (2) cosmetics: including cosmeceuticals for example for wound healing, burns, psoriasis and wrinkles; (3) detergents and cleaners: particularly for laundry products, shampoos and soaps given their surface active and emulsification properties and (4) agriculture.
  • EOR enhanced oil recovery
  • detergents and cleaners particularly for laundry products, shampoos and soaps given their surface active and emulsification properties and (4) agriculture.
  • Rhamnolipids are currently available in an agricultural anti-fungal product marketed as ZONIXTM (Pro
  • rhamnolipids have only been available on the market in small amounts and at high prices partially due to cumbersome downstream processing methods.
  • Various methods have been disclosed for producing rhamnolipids (reviewed in, for example, Heyd et al. (2008)
  • hydrophobic impurities with it potentially including unconsumed triacyl glyceride oil and antifoam from the fermentation process.
  • examples of other methods disclosed include (1) aluminum sulphate precipitation of fermentation broth followed by extraction with organic solvent; (2) continuous ultrafiltration; (3) column
  • composition comprising rhamnolipids comprising:
  • the final product using the method set forth above comes from a natural process, has not been chemically modified, and has not come in contact with any petroleum based organic solvents.
  • the process or method set forth above eliminates the use of petroleum derived chemical solvents to extract rhamnolipids from aqueous medium (e.g., fermented medium or broth) and thus, it significantly reduces the production cost. Furthermore, the final rhamnolipid solution is naturally derived.
  • the composition comprising rhamnolipids is a clarified broth comprising at least about 5%, 6%, 7%, 8%, 9%, or 10% rhamnolipids by weight, wherein said method further comprises after step (a) and before step (b), (1) aging said medium provided in step (a) to obtain aged and sterilized medium. Also provided is a composition comprising said aged and sterilized medium obtainable from the process set forth above. The method may further comprise after step (a) and before step (b) removing solid waste from said medium provided in step (a).
  • the composition in the above specific embodiments may comprise between about 5% to about 10% RL.
  • the method may further comprise after the sterilization step (b) and before the separation step (c) aging said sterilized medium of step (a).
  • step (a) and before said medium is aged in (1) solid waste may be removed from medium provided.
  • the method comprises two aging steps and may comprise the following steps:
  • aqueous medium e.g., fermentation medium
  • aqueous medium comprising at least one rhamnolipid
  • aqueous medium e.g., fermentation medium
  • a composition comprising rhamnolipids may be a clarified broth which comprises at least about 5%, 6%, 7%, 8% 9%, or 10% rhamnolipids by weight.
  • the method for obtaining the composition comprising RLs, particularly a clarified broth may, comprise before step
  • step (b) aging said medium provided in step (a) then subsequently (b) sterilizing said aged medium via chemical treatment, in particular, peroxide treatment (e.g., hydrogen peroxide, and organic peroxides such as benzoyl peroxide and peroxyacetic acid and inorganic peroxides such as lithium peroxide, sodium peroxide, barium peroxide), and/or ultraviolet light radiation treatment; (c) separating a RL containing phase from the solid waste in said sterilized medium and optionally further comprising (c) (1) additionally sterilizing said RL containing phase and (c)(2) separating a RL containing phase from solid waste in said sterilized RL containing phase to obtain said clarified broth.
  • said sterilization step in step (b) is via chemical treatment and/or ultraviolet radiation treatment and the sterilization step in step
  • compositions obtainable after sterilizing said aged medium. Further provided are sterilized compositions obtainable using steps (b) and/or (c)(1) set forth above.
  • the methods set forth above may further comprise a decolorization and/or deodorization step.
  • the decolorization and/or deodorization treatment may be performed before and/or after the sterilization step.
  • a composition comprising decolorized and/or deodorized medium obtainable using the methods set forth above.
  • fluid or liquid may be removed from the separated RL containing phase to obtain a solid composition for example, by evaporation.
  • said composition is in for example, powder form or granular form.
  • said composition comprising rhamnolipids is a concentrated clarified broth comprising at least about 30%, at least about 35%, at least about 40%, at least about 45%, at least about 50% or at least about 60% rhamnolipids by weight.
  • said concentrated clarified broth may comprise between about 30— 60% RL, about 30-40% RL or about 50-60% RL by weight.
  • said medium provided in step (a) in the method set forth above is sterilized in step (b) by treating said medium with acid and said acidic medium obtained comprises a solid, liquid and oily phase and at least the liquid phase is removed and before step (c), the solid and optionally oily phases are neutralized to obtain a solution and in step (c) insoluble waste material is removed from said solution to obtain said composition comprising said concentrated clarified broth set forth above.
  • a method for obtaining concentrated clarified broth may comprise:
  • aqueous medium e.g., fermentation medium
  • RLs rhamnolipids
  • said method may further comprise an additional sterilization step and optionally a further separation step to remove insoluble waste from said solution. Furthermore, said method may further comprise after
  • the method may also further comprise removing liquid or fluid from said solution by evaporation obtained in step (c) to obtain a solid composition.
  • the medium may be treated with acid and then neutralized either before or after the additional sterilization step.
  • said solid and oily phases may be neutralized separately to obtain separate solutions.
  • said solid and oily phases are combined and said combined solid and oily phases are neutralized to obtain a neutralized solution.
  • only the solid phase is neutralized.
  • the methods set forth above may further comprise decolorizing and/deodorizing said composition. Additionally, said composition may be dried.
  • a method for obtaining a composition comprising rhamnolipids which is a concentrated clarified broth comprising at least about 30%, at least about 35%, at least about 40%, at least about 45%, at least about 50% or at least about 60%rhamnolipids by weight, may further comprise before and/or after said additional sterilization step aging said medium provided.
  • said method comprises:
  • compositions comprising the neutralized solution obtainable according to the methods set forth above.
  • decolorized and/or deodorized compositions comprising at least about 30% RLs using or obtainable from methods set forth above.
  • compositions obtained may be used as a surfactant in hand soaps, body washes, facial cleansers, tooth paste, shampoos, conditioners, conditioning shampoos, cosmetics, dish soap, laundry detergents, laundry pretreatment sprays, hard surface cleaners, porous surface cleaners, floor cleaners, automobile cleaners, enhanced oil recovery, wound dressings, agricultural anti-bacterials, anti-corrosion treatments, bioremediation, anti-stick films, anti-biofouling applications, fire extinguishing media, anti-virals, anti-molds, and anti-zoosporics.
  • compositions containing higher amounts of RL (>30% wt/vol) or more particularly about (>50% wt/vol) obtained using the methods set forth above can be used to make a rhamnolipid based product that can displace an anionic surfactant such as sodium lauryl sulfate (SLS) in personal care and household cleaner markets given that certain anionic surfactants are often sold at a concentration of about 30% for some application.
  • SLS sodium lauryl sulfate
  • Figure 1 schematically shows an organic solvent free method for obtaining rhamnolipid rich clarified broth (CB).
  • FIG. 1 schematically shows were the CB is concentrated by acid/base treatment to obtain concentrated clarified broth (CCB).
  • Figure 3 schematically shows obtaining CCB from hydrogen peroxide treated
  • Figure 4 schematically shows obtaining CCB from hydrogen peroxide treated sterilized fermentation medium.
  • Figure 5 schematically shows obtaining CCB by first performing a separation step on the fermentation broth and performing the sterilization step later in the process.
  • Figure 6 schematically shows a method for obtaining CCB by performing separation, sterilization, aging and acidification steps.
  • rhamnolipid refers to a glycolipid that has a lipid portion that includes one or more, typically linear, saturated or unsaturated ⁇ -hydroxy- carboxylic acid moieties and a saccharide portion of one or more units of rhamnose.
  • the saccharide portion and the lipid portion are linked via a ⁇ - glycosidic bond between the 1-OH group of a rhamnose moiety of the saccharide portion and the 3-0H group of a ⁇ -hydroxy-carboxylic acid of the lipid portion.
  • the carboxylic group of one carboxylic acid moiety defines the end of the rhanmolipid.
  • each of the rhamnose moieties not linked to the lipid portion is linked to another rhamnose moiety via a 1,4 ⁇ -glycosidic bond.
  • the ⁇ -hydroxy-carboxylic acid moieties are selected independently from each other, ⁇ -hydroxy carboxylic acid moieties of a respective plurality of ⁇ -hydroxy carboxylic acid moieties may in some embodiments be identical. In some
  • an aqueous medium is a composition which comprises at least about 5% by weight of rhamnolipids or salts of rhamnolipids in water. In a particular embodiment, it comprises the product of a fermentation that has the ability to produce one or more rhamnolipids from at least one carbon source under fermentation conditions known in the art.
  • fermentation broth and “fermentation medium” are synonymous and may be used interchangeably.
  • the rhamnolipid may have the structure (I)
  • R 9 is a hydrogen atom (H) or an aliphatic group that has a main chain of one to about 46, such as one to about 42, one to about 40, one to about 38, one to about 36, one to about 34, one to about 30, one to about 28, including e.g. 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 or 28 carbon atoms and one to about three, including two, oxygen atoms.
  • the main chain of the respective aliphatic group carries a terminal carboxylic acid group and/or an internal ester group.
  • R 9 may be of the formula— CH(R 5 )— CH 2 — COOR 6 .
  • R 5 may be an aliphatic moiety with a main chain that has a length from 1 to about 19, such as from 1 to about 17, from 1 to about 15, from 1 to about 13, about 2 to about 13, about 3 to about 13 or about 4 to about 13, including e.g. 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms.
  • R 4 in formula (I) is a hydrogen atom (H), or a rhamnopyranosyl moiety.
  • R 6 is a hydrogen atom.
  • aliphatic means, unless otherwise stated, a straight or branched hydrocarbon chain, which may be saturated or mono- or po!y-unsaturated and include heteroatoms.
  • heteroatom as used herein means an atom of any element other than carbon or hydrogen.
  • an unsaturated aliphatic group contains one or more double bonds (alkenyl moieties).
  • the branches of the hydrocarbon chain may include linear chains as well as non-aromatic cyclic elements.
  • the hydrocarbon chain which may, unless otherwise stated, be of any length, and contain any number of branches.
  • the hydrocarbon (main) chain includes 1 to about 5, to about 10, to about 15 or to about 20 carbon atoms.
  • alkenyl moieties are straight- chain or branched hydrocarbon moieties which contain one or more double bonds.
  • Alkenyl moieties generally contain about two to about twenty carbon atoms and one or more, for instance two, double bonds, such as about two to about ten carbon atoms, and one double bond.
  • alkyl groups are methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, the n isomers of these radicals, isopropyl, isobutyl, isopentyl, sec-butyl, tert-butyl, neopentyl, 3,3-dimethylbutyl.
  • Both the main chain as well as the branches may furthermore contain heteroatoms as for instance N, 0, S, Se or Si or a carbon atom may be replaced by one of these heteroatoms.
  • An aliphatic moiety may be substituted or unsubstituted with one or more functional groups.
  • Substituents may be any functional group, as for example, but not limited to, amino, amido, carbonyl, carboxyl, hydroxyl, nitro, thio and sulfonyi.
  • the rhamnolipid(s) or rhamnolipid salts in said structure has the structure (II):
  • the mono-rhamnolipid may be referred to as Rha-ClO-CIO, with a formula of C 2 6H 4 80 9 .
  • the IUPAC Name is 3-[3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6- methyloxan-2-yl]oxydecanoyloxy]decanoic acid.
  • the di-rhamnolipid may be referred to as RhaRha-ClO-CIO, with a formula of C 32 H 5 80i 3 .
  • the IUPAC name is 3-[3-[4,5- dihydroxy-6-methyl-3-(3,4, 5-tri hydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy decanoyloxyjdecanoic acid.
  • mono-rhamnolipid may be present in the amount of about from 30% of total rhamnolipid to about 50% of total and di-rhamnolipid may be present in the amount of about from 50% of total rhamnolipid to about 70% di-rhamnolipid.
  • the composition in another embodiment comprises mono and di-rhamnolipids wherein the ratio of mono-rhamnolipids:di- rhamnolipids is from about 35:65 to about 55:45
  • the composition comprises the compounds set forth in Table 1.
  • the method comprises: (a) providing an aqueous medium comprising at least one rhamnolipid (RL); (b) non-mechanical sterilization of said medium provided in (a) and (c) separating a RL containing phase in the sterilized medium of (b) from waste to obtain said composition.
  • aqueous medium comprising at least one rhamnolipid (RL)
  • RL rhamnolipid
  • non-mechanical sterilization of said medium provided in (a)
  • separating a RL containing phase in the sterilized medium of (b) from waste to obtain said composition aging, acidification, neutralization, drying, decolorization and/or deodorization steps may also be used.
  • Source of medium may also be used.
  • the aqueous medium provided comprising one or more rhamnolipids may be obtainable from a fermentation broth derived from and in particular, may be a result of a recombinant host cell producing rhamnolipids using methods known in the art or from a rhamnolipid producing microorganism.
  • a recombinant host cell producing rhamnolipids may be a host cell, such as a bacterial cell that expresses a RhlA gene or ortholog thereof and/or a RhlB gene or ortholog thereof, and/or a RhlC gene or ortholog thereof, and/or RhlR gene or ortholog thereof, and/or Rhll gene or ortholog thereof, and/or RhlG gene or ortholog thereof and others.
  • rhamnolipid-producing microorganism refers to any microorganism, such as bacteria, which has the capacity to synthesize/produce rhamnolipids under suitable conditions which includes but is not limited to bacterium of the phyla Actinobacteria, Fimicutes and Proteobacteria.
  • bacterium of the phyla Actinobacteria bacterium of the phyla Actinobacteria, Fimicutes and Proteobacteria.
  • the rhamnolipid-producing microorganism is a bacterium of the
  • the rhamnolipid-producing microorganism is a bacterium of the Pseudomonadales order. In yet another further embodiment, the rhamnolipid producing microorganism is a bacterium of the
  • the rhamnolipid-producing microorganism is a bacterium of the Pseudomonas genus, such as P. alcaligenes, P. aeruginosa, P. chlororaphis, P. clemancea, P. collierea, P. fluorescens, P. luteola, P.
  • the rhamnolipid- producing microorganism is P. aeruginosa.
  • the host cell is cultured under conditions that allow RL production.
  • carbon sources may be used such as a monosaccharide, e.g. glucose, a disaccharide, e.g. sucrose, an alcohol, e.g. glycerol, an alkane, e.g., n-hexadecane, a fatty acid such as caprylic acid (also termed octanoate), vegetable oils (fresh or waste; e.g., soybean oil) or mixtures thereof, organic acids (e.g. lactic acid, acetic acid, citric acid, propionic acid), alcohols (e.g.
  • the bacterial host cell will typically be exposed to a fermentation process.
  • the bacterial host cell may for instance be in the logarithmic growth phase or in the stationary phase. Sterilization
  • the aqueous (e.g., fermentation) medium provided is sterilized.
  • the medium in the the methods set forth above may be sterilized by non filtration methods using methods known in the art. These methods may be either heat based, chemical based or ultraviolet light radiation based.
  • the heat based treatment may be via moist heat sterilization, particularly autoclaving.
  • the fermentation medium may be treated chemically.
  • the chemical treatment may be via acidification, removal of solid waste and neutralization using procedures set forth below.
  • the aqueous (e.g. fermentation) medium may be treated with peroxides such as hydrogen peroxide, lithium peroxide, sodium peroxide, barium peroxide, peroxyacetic acid, benzoyl peroxide, in particular, hydrogen peroxide using methods known in the art and set forth below.
  • peroxides such as hydrogen peroxide, lithium peroxide, sodium peroxide, barium peroxide, peroxyacetic acid, benzoyl peroxide, in particular, hydrogen peroxide using methods known in the art and set forth below.
  • the aqueous medium may be irradiated with, for example, ultraviolet light irradiation.
  • the aqueous medium e.g., fermentation medium or broth
  • the fermentation media may be sterilized by more than one of the procedures set forth above and these sterilizations could be in any order.
  • Waste from the compositions and/or medium obtained using the medium set forth herein may be be removed or separated from the composition using separation procedures known in the art. These procedures include but are not limited to, settling batch or continuous centrifugation or ultracentrifugation, which may be followed by decantation or filtration using procedures known in the art.
  • the waste can be either a solid phase or a liquid phase, depending on where in the process the separation occurs.
  • the culture or fermentation medium may be aged by incubating for at least about 1 day and between about 24-72 hrs. at between about 0-30C. This aging step may occur before and/or after one or more of the sterilization steps set forth above. Acidification/Neutralization
  • Aqueous (e.g. Fermentation) medium may be concentrated or sterilized by treating with acid, removing liquid waste and then neutralizing the remaining solid and optionally oily phase or layer.
  • the aqueous medium may be treated with acid so the culture medium is adjusted to a pH of between about 1.5 to 2.5, preferentially, about 2.05 to about 2.15.
  • the acid can be an organic acid such as acetic acid, or a mineral acid.
  • the acid is a mineral acid, e.g. HC1, H2SO4, HNO3, or H3CIO4,.
  • the solid and optionally the oily phase are neutralized to a pH greater than about 5.5, preferably between about 6.5-7.5, more preferably between about 6.9-7.1.
  • the solid and optionally oily phase is treated with a solid, dry mineral base (e.g., NaOH, KOH, LiOH, NaHC0 3 ).
  • a solid, dry mineral base e.g., NaOH, KOH, LiOH, NaHC0 3 .
  • these phases may be combined and neutralized or alternatively neutralized separately.
  • solid waste is removed by methods set forth above, including but not limited to filtration, settling or
  • the neutralized material may also be subjected to a further sterilization step, as set forth above.
  • the aqueous medium e.g., fermentation medium or broth
  • the aqueous medium may be decolorized and/or deodorized using procedures know in the art.
  • chemical and/or ultraviolet or visible radiation treatment is used.
  • said decolorization and/or deodorization step may be accomplished via peroxide treatment using either hydrogen peroxide or organic (e.g, benzoyl peroxide or peroxyacetic acid) or inorganic peroxide (e.g., lithium peroxide, sodium peroxide, barium peroxide).
  • the aqueous medium e.g., fermentation medium or broth
  • peroxide particularly, hydrogen peroxide, at a concentration of about 1-5% v/v for about 48- 120 hours and more particularly between about 3-4% v/v for about 72-96 hours.
  • the aqueous medium may be decolorized and/or deodorized via ultraviolet or visible radiation from 350 - 550 nm, preferentially 400-450 nm.
  • the dose of radiation needs to be at least about 100 J/g of rhamnolipids, preferentially at least about 1 kj/g, more preferentially at least about 10 kj/g.
  • This aqueous medium may be decolorized and/or deodorized before and/or after sterilization and before or after the acidification and neutralization process described above.
  • the liquid may be removed after removal of solid waste using methods known in the art, with the proviso that it does not follow decolorization and/or deodorization by peroxide treatment. These include but are not limited to heat, evaporation, freeze drying (lyophilization), drum drying. DESCRIPTION OF SPECIFIC EMBODIMENTS
  • Example 1 A process to recover a rhamnolipid (RL) rich solution (clarified broth) from fermentation broth without the use of organic solvent
  • the process utilizes aging at room temperature, followed by autoclaving, and standard solid/liquid separation techniques to separate clarified rhamnolipid rich solution contained at least 50 g/L from bacterial cell matter.
  • the rhamnolipid containing broth is generated from the fermentation by Pseudomonas aeruginosa at pH 6.2-6.5 at 37C for 48-72 hours with soybean oil as the feedstock.
  • the final pH of fermentation broth prior to aging is in the range of 6.4-6.5.
  • the fermentation broth is sterilized by steam heating or autoclaving.
  • solid/liquid separation the rhamnolipid solution is clear and ready to be used.
  • the dark brown color of the rhamnolipid solution can be reduced with the addition of hydrogen peroxide at 2-3% v/v over 72-96 hrs. at room
  • peroxides can also be used in this step, including organic (e.g, benzoyl peroxide or peroxyacetic acid) or inorganic peroxide (e.g., lithium peroxide, sodium peroxide, barium peroxide).
  • organic peroxide e.g., benzoyl peroxide or peroxyacetic acid
  • inorganic peroxide e.g., lithium peroxide, sodium peroxide, barium peroxide
  • the clarified rhamnolipid rich solution if not treated with peroxide, can also be lyophilized to produce a lightly colored powder.
  • a rhamnolipid rich powder (>75% active) is obtained.
  • Example 2 Isolation of an aqueous solution of rhamnolipids by precipitation from clarified fermentation broth and redissolution in base and the composition that results from the process
  • the current process starts with the clarified broth obtained in Example 1 and is depicted schematically in Figure 2.
  • clarified broth is made by allowing fermentation broth that ends at a pH of 6.0 to 6.5 to age under ambient conditions for about 2 days.
  • the biomass settles to the bottom of the vessel used for this aging process and the clear supernatant, after removal, is clarified broth.
  • the next step in the process is to add acid, such as concentrated sulfuric acid, until the pH is about 2.1.
  • the rhamnolipids precipitate out of solution and form a solid phase and an oily liquid phase at the bottom of the vessel used for this step.
  • the separation of the solid and oily liquid phases can be sped up by centrifugation.
  • the solid and oily liquid phases are separated from the aqueous top phase or layer, which can be discarded or recycled.
  • the combined solid and oily liquid rhamnolipid containing phases are then treated with a solid base, such as sodium hydroxide, until the pH reaches about 7.0. This produces a viscous solution of rhamnolipids in water with a concentration of about 25 to 30%.
  • the final step is to centrifuge the 25-30% rhamnolipid solution and decant the liquid final product away from the pellet formed from any remaining solids. This liquid can be lyophilized (freeze dried) to produce a dry solid product.
  • Example 3 Non-organic solvent concentrated process to produce 35-40% rhamnolipid solution using a pH shift
  • rhamnolipid solution using a pH shift starting with "reduced color and odor clarified broth” as described in Example 1 or "reduced color and odor sterilized fermentation broth” and are schematically depicted in Figures 3 and 4.
  • the "reduced color and odor clarified broth” and “reduced color and odor sterilized fermentation broth” can be obtained by adding 3-5 % v/v hydrogen peroxide to clarified broth or sterilized fermentation broth respectively. After 72-96 hours at room temperature, the color of the clarified rhamnolipid rich solution is slightly yellow with no loss in rhamnolipids and odor is reduced.
  • the reduced color and odor clarified broth is filtered at 1 micron by cross flow filtration or solids are removed by centrifugation followed by decanting.
  • the concentrated acid such as sulfuric acid is added into the filtrate (permeate) or supernatant until the pH is about 2.1.
  • the mixture is then allowed to separate into a rhamnolipid rich layer made up of a solid phase and an oily liquid phase at the bottom of the container.
  • the combined solid and oily liquid rhamnolipid containing phases are then separated from the aqueous top layer and treated with a solid base, such as sodium hydroxide, until the pH reaches about 7.0. This produces a viscous solution of rhamnolipids in water.
  • the final step is to centrifuge the resulting rhamnolipid solution and remove the liquid final product from the pellet formed from any remaining solids.
  • the final liquid product is 30-40% rhamnolipids.
  • Example 4 Process for isolating rhamnolipids from fermentation broth with sterilization at end of the process and materials produced during the process
  • the process begins by doing a solid/liquid separation process such as centrifugation or filtration of fermentation broth that still contains a living organism that produces rhamnolipids.
  • the clarified liquid product is then acidified to pH 2.1 using concentrated sulfuric acid, or another concentrated, strong mineral acid.
  • the water layer is decanted away from the denser product, which is an oily layer and a solid layer.
  • This oily and/or solid layer is neutralized to pH 7 with a solid base such as sodium hydroxide, resulting in a solution.
  • Example 5 Non-organic solvent concentrated process to produce 50-60% rhamnolipid solution using a pH shift Provided is a modification of the process disclosed in Example 3, "Non-organic solvent concentrated process to produce 30-40% rhamnolipid solution using a pH shift" to produce 50-60% rhamnolipid solution.
  • a preparation of clarified broth and the acid precipitation of the clarified broth with concentrated sulfuric acid (95-98 wt%) to pH 2.1 remain the same as disclosed in Example 3.
  • the mixture is then allowed to separate into a rhamnolipid rich layer made up of a solid phase and an oily liquid phase at the bottom of the container.
  • the oily material and the solid are separated using, for example centrifugation. After centrifugation, the solid is obtained at the bottom and the oily material is at the middle while the aqueous top layer is at the top of the vessel.
  • the solids are then separated from oily liquid rhamnolipid containing phases and are treated with a solid base, such as sodium hydroxide until the pH reaches about 7.0 at which the product liquefies.
  • the final step is to centrifuge the resulting rhamnolipid solution and remove the liquid final product from the pellet formed from any remaining solids.
  • the final liquid product is 50-60% rhamnolipids and is part of the invention. This liquid may be lyophilized (freeze dried) to produce a dry solid product, which is also part of the invention.
  • Example 6 Process for isolating rhamnolipid from fermentation broth before sterilization to obtain high rhamnolipid concentration without solvent extraction
  • This process is a modification of the process described in Example 5: "Non- organic solvent concentrated process to produce 50-60% rhamnolipid solution using a pH shift" to produce 50-60% rhamnolipid solution but at a higher yield since it includes the oily layer obtained after acid precipitation and thus, increasing the recovery of rhamnolipids.
  • the process is depicted in Figure 6. It begins with fermentation broth that contains rhamnolipids and biomass from cells that produced the rhamnolipids, preferentially Pseudomonas aeruginosa. First, centrifugation is performed at at least 7500 g for at least 5 min. A clarified broth (CB) is then separated from microbial cells (solid) and is sterilized via steam autoclave. The CB is then allowed to settle, preferably overnight, prior to being centrifuged or filtered to remove any additional solids that precipitated out during settling.
  • CB clarified broth
  • solid microbial cells
  • This further clarified CB is then acidified to pH 2.1 using concentrated sulfuric acid, or another concentrated, strong mineral acid.
  • the acidified clarified broth is part of the invention. After settling or centrifugation, the water layer is decanted away from a solid layer. The solid is then treated with a solid base, such as sodium hydroxide, until the pH reaches about 7.0. The result is a liquid with 50-60% rhamnolipids. This liquid can be lyophilized (freeze dried) to produce a dry solid product.
  • the overall process produces a product that is a high concentration of rhamnolipid biosurfactant cost effectively with a recovery rate of the rhamnolipids in the original fermentation broth of about >80%. This solves the problem that it is perceived that isolating products from rhamnolipid fermentations is too expensive to be commercially viable.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des procédés sans solvant organique pour obtenir des compositions comprenant un ou plusieurs rhamnolipides ainsi que des compositions pouvant être obtenues au moyen de ces procédés.
PCT/US2016/012901 2015-01-12 2016-01-11 Production de compositions à base de rhamnolipides Ceased WO2016115048A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
CN202110544567.5A CN113368777B (zh) 2015-01-12 2016-01-11 鼠李糖脂组合物的制备
HK18106777.6A HK1247249A1 (zh) 2015-01-12 2016-01-11 鼠李糖脂组合物的制备
KR1020177021080A KR102557083B1 (ko) 2015-01-12 2016-01-11 람노리피드 조성물의 제조
CN201680014963.4A CN107406867B (zh) 2015-01-12 2016-01-11 鼠李糖脂组合物的制备
EP16737680.5A EP3245293B1 (fr) 2015-01-12 2016-01-11 Production de compositions à base de rhamnolipides
JP2017555441A JP6866301B2 (ja) 2015-01-12 2016-01-11 ラムノリピド組成物の製造
CA2973183A CA2973183C (fr) 2015-01-12 2016-01-11 Production de compositions a base de rhamnolipides
MX2017009126A MX2017009126A (es) 2015-01-12 2016-01-11 Produccion de composiciones de ramnolipidos.
AU2016207008A AU2016207008B2 (en) 2015-01-12 2016-01-11 Production of rhamnolipid compositions
BR112017014710-6A BR112017014710B1 (pt) 2015-01-12 2016-01-11 Processo livre de solvente orgânico para a obtenção de uma composição compreendendo um ou mais ramnolipídeos (rls) e composições

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201562102310P 2015-01-12 2015-01-12
US62/102,310 2015-01-12
US201562141679P 2015-04-01 2015-04-01
US62/141,679 2015-04-01
US201562157019P 2015-05-05 2015-05-05
US62/157,019 2015-05-05
US201562198740P 2015-07-30 2015-07-30
US201562198736P 2015-07-30 2015-07-30
US62/198,736 2015-07-30
US62/198,740 2015-07-30

Publications (2)

Publication Number Publication Date
WO2016115048A1 true WO2016115048A1 (fr) 2016-07-21
WO2016115048A8 WO2016115048A8 (fr) 2017-04-20

Family

ID=56406261

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/012901 Ceased WO2016115048A1 (fr) 2015-01-12 2016-01-11 Production de compositions à base de rhamnolipides

Country Status (1)

Country Link
WO (1) WO2016115048A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018144053A1 (fr) 2017-02-06 2018-08-09 Logos Technologies, Llc Décoloration de composition concentrée de rhamnolipides
JP2020517254A (ja) * 2017-04-20 2020-06-18 ローカス アイピー カンパニー、エルエルシー 養殖及び水槽における養魚を改善するコスト効率の良い組成物及び方法
EP3584814A4 (fr) * 2017-02-17 2020-12-16 Fujifilm Corporation Élément de conversion photoélectrique, cellule solaire à colorant, colorant au complexe métallique, solution de colorant et électrode semi-conductrice d'oxyde
WO2022233700A1 (fr) 2021-05-05 2022-11-10 Evonik Operations Gmbh Compositions contenant au moins un biotensioactif et au moins un dérivé d'acide sulfonique ou sulfinique
WO2024076921A1 (fr) * 2022-10-03 2024-04-11 Stepan Company Procédé et composition pour lutter contre l'acné à l'aide de rhamnolipides

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628030A (en) 1983-08-09 1986-12-09 Petrotec Forschungs Ag Process for the production of rhamnolipids
US5656747A (en) 1992-11-05 1997-08-12 Hoechst Aktiengesellschaft Process for the quantitative purification of glycolipids
US6060287A (en) 1997-02-25 2000-05-09 Universidad Simon Bolivar Production of oily emulsions mediated by a microbial tenso-active agent
KR20060018783A (ko) 2004-08-24 2006-03-02 공재열 해양세균 슈도모나스 아에루기노사(Pseudomonasaeruginosa) BYK-2에 의해 생산되는 당지질 생물유화제 및그 정제방법
CN1908180A (zh) 2006-08-08 2007-02-07 浙江大学 餐饮废油发酵生产鼠李糖脂粗提物及其用途
US7202063B1 (en) 2004-09-01 2007-04-10 United States Of America As Represented By The Secretary Of Agriculture Processes for the production of rhamnolipids
CN101407831A (zh) 2008-10-15 2009-04-15 辛明秀 一种大孔树脂制备鼠李糖脂的方法
CN101787057A (zh) 2010-02-09 2010-07-28 华东理工大学 一种鼠李糖脂的分离纯化方法
CN101845468A (zh) 2010-03-30 2010-09-29 湖州紫金生物科技有限公司 一种鼠李糖脂的制备方法及其应用
CN102432643A (zh) 2011-10-16 2012-05-02 湖州紫金生物科技有限公司 一种超滤膜应用于鼠李糖脂的分离方法
CN102766172A (zh) 2011-09-19 2012-11-07 大庆沃太斯化工有限公司 一种鼠李糖脂生物表面活性剂干粉的工业化生产方法
CN102796781A (zh) 2012-08-08 2012-11-28 中国海洋石油总公司 用铜绿假单胞杆菌发酵、分离生产鼠李糖脂的方法
WO2014039940A1 (fr) 2012-09-10 2014-03-13 Logos Technologies Llc Cellules et méthodes de production de rhamnolipides
US20140148588A1 (en) 2012-11-26 2014-05-29 Evonik Industries Ag Process for the isolation of rhamnolipids
US20150011741A1 (en) 2011-12-12 2015-01-08 Technische Universitaet Dortmund Foam adsorption
EP3023431A1 (fr) 2014-11-19 2016-05-25 Evonik Degussa GmbH Compositions de rhamnolipides concentrées et peu visqueuses

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628030A (en) 1983-08-09 1986-12-09 Petrotec Forschungs Ag Process for the production of rhamnolipids
US5656747A (en) 1992-11-05 1997-08-12 Hoechst Aktiengesellschaft Process for the quantitative purification of glycolipids
US6060287A (en) 1997-02-25 2000-05-09 Universidad Simon Bolivar Production of oily emulsions mediated by a microbial tenso-active agent
KR20060018783A (ko) 2004-08-24 2006-03-02 공재열 해양세균 슈도모나스 아에루기노사(Pseudomonasaeruginosa) BYK-2에 의해 생산되는 당지질 생물유화제 및그 정제방법
US7202063B1 (en) 2004-09-01 2007-04-10 United States Of America As Represented By The Secretary Of Agriculture Processes for the production of rhamnolipids
CN1908180A (zh) 2006-08-08 2007-02-07 浙江大学 餐饮废油发酵生产鼠李糖脂粗提物及其用途
CN101407831A (zh) 2008-10-15 2009-04-15 辛明秀 一种大孔树脂制备鼠李糖脂的方法
CN101787057A (zh) 2010-02-09 2010-07-28 华东理工大学 一种鼠李糖脂的分离纯化方法
CN101845468A (zh) 2010-03-30 2010-09-29 湖州紫金生物科技有限公司 一种鼠李糖脂的制备方法及其应用
CN102766172A (zh) 2011-09-19 2012-11-07 大庆沃太斯化工有限公司 一种鼠李糖脂生物表面活性剂干粉的工业化生产方法
CN102432643A (zh) 2011-10-16 2012-05-02 湖州紫金生物科技有限公司 一种超滤膜应用于鼠李糖脂的分离方法
US20150011741A1 (en) 2011-12-12 2015-01-08 Technische Universitaet Dortmund Foam adsorption
CN102796781A (zh) 2012-08-08 2012-11-28 中国海洋石油总公司 用铜绿假单胞杆菌发酵、分离生产鼠李糖脂的方法
WO2014039940A1 (fr) 2012-09-10 2014-03-13 Logos Technologies Llc Cellules et méthodes de production de rhamnolipides
US20140148588A1 (en) 2012-11-26 2014-05-29 Evonik Industries Ag Process for the isolation of rhamnolipids
EP3023431A1 (fr) 2014-11-19 2016-05-25 Evonik Degussa GmbH Compositions de rhamnolipides concentrées et peu visqueuses

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
BANAT: "Microbial biosurfactants production, applications and future potential", APPL MICROBIOL BIOTECHNOL, vol. 87, 2010, pages 427 - 444, XP019841587
DESAI ET AL.: "Microbial Production of Surfactants and Their Commercial Potential", MICROBIOL. MOL. BIOL. REV., vol. 61, 1997, pages 47 - 64, XP002209696
HEYD ET AL.: "Development and trends of biosurfactant analysis and purification using rhamnolipids as an example", ANAL BIOANAL CHEM, vol. 391, 2008, pages 1579 - 1590, XP019621251
LEBRON-PALER A: "PhD Dissertation", 2008, UNIVERSITY OF ARIZONA, article "Solution and interfacial characterization of rhamnolipid biosurfactant from P. aeruginosa ATCC 9027"
MULLER ET AL.: "Rhamnolipids-Next generation surfactants?", J BIOTECHNOL, vol. 162, no. 4, 2012, pages 366 - 80, XP055489735, DOI: 10.1016/j.jbiotec.2012.05.022
RANDHAWA ET AL.: "Rhamnolipid biosurfactants—past, present, and future scenario of global market", FRONTIERS IN MICROBIOLOGY, vol. 5, 2014, pages 1 - 7, XP055812420, DOI: 10.3389/fmicb.2014.00454
RIKALOVIC, MILENA G. ET AL.: "Production and characterization of rhamnolipids from Pseudomonas aeruginosa san-ai", JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, vol. 77, no. 1, 2012, pages 27 - 42, XP055464574 *
RIKALOVIC: "Production and characterization of rhamnolipids from Pseudomonas aeruginosa san-ai", J. SERB. CHEM. SOC., vol. 77, 2012, pages 27 - 42, XP055464574, DOI: 10.2298/JSC110211156R
SARACHAT ET AL.: "Purification and concentration of a rhamnolipid biosurfactant produced by Pseudomonas aeruginosa SP4 using foam fractionation", BIORESOURCE TECHNOLOGY, vol. 101, 2010, pages 324 - 330, XP026624010, DOI: 10.1016/j.biortech.2009.08.012
See also references of EP3245293A4
SMYTH: "Handbook of Hydrocarbon and Lipid Microbiology", 2010, SPRINGER-VERLAG, article "Isolation and Analysis of Low Molecular Weight Microbial Glycolipids", pages: 3705 - 3724
WITEK-KROWIAK ET AL.: "Ultrafiltrative separation of rhamnolipid from culture medium", WORLD J. MICROBIOL. BIOTECHNOL., vol. 27, 2011, pages 1961 - 1964, XP019929040, DOI: 10.1007/s11274-011-0655-0
WITEK-KROWIAK, ANNA ET AL.: "Ultrafiltrative separation of rhamnolipid from culture medium", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 27, no. 8, 2011, pages 1961 - 1964, XP019929040 *
ZHANG ET AL.: "Separation and purification of six biosurfactant rhamnolipids by high-speed countercurrent chromatography utilizing novel solvent selection method", SEPARATION SCIENCE AND TECHNOLOGY, 24 November 2015 (2015-11-24)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102431805B1 (ko) * 2017-02-06 2022-08-10 스테판 컴파니 농축된 람노리피드 조성물의 탈색
CN110248952A (zh) * 2017-02-06 2019-09-17 罗格斯技术有限责任公司 浓缩鼠李糖脂组合物的脱色
KR20190107126A (ko) * 2017-02-06 2019-09-18 로고스 테크놀로지스, 엘엘씨 농축된 람노리피드 조성물의 탈색
JP2020506199A (ja) * 2017-02-06 2020-02-27 ロゴス テクノロジーズ， エルエルシー．Ｌｏｇｏｓ Ｔｅｃｈｎｏｌｏｇｉｅｓ， Ｌｌｃ． 濃縮ラムノリピド組成物の脱色
EP3577126A4 (fr) * 2017-02-06 2020-12-09 Stepan Company Décoloration de composition concentrée de rhamnolipides
AU2017397426B2 (en) * 2017-02-06 2021-12-09 Stepan Company Decolorization of concentrated rhamnolipid composition
JP7022139B2 (ja) 2017-02-06 2022-02-17 ステパン カンパニー 濃縮ラムノリピド組成物の脱色
WO2018144053A1 (fr) 2017-02-06 2018-08-09 Logos Technologies, Llc Décoloration de composition concentrée de rhamnolipides
CN110248952B (zh) * 2017-02-06 2023-11-14 斯泰潘公司 浓缩鼠李糖脂组合物的脱色
EP3584814A4 (fr) * 2017-02-17 2020-12-16 Fujifilm Corporation Élément de conversion photoélectrique, cellule solaire à colorant, colorant au complexe métallique, solution de colorant et électrode semi-conductrice d'oxyde
JP2020517254A (ja) * 2017-04-20 2020-06-18 ローカス アイピー カンパニー、エルエルシー 養殖及び水槽における養魚を改善するコスト効率の良い組成物及び方法
WO2022233700A1 (fr) 2021-05-05 2022-11-10 Evonik Operations Gmbh Compositions contenant au moins un biotensioactif et au moins un dérivé d'acide sulfonique ou sulfinique
WO2024076921A1 (fr) * 2022-10-03 2024-04-11 Stepan Company Procédé et composition pour lutter contre l'acné à l'aide de rhamnolipides

Also Published As

Publication number Publication date
WO2016115048A8 (fr) 2017-04-20

Similar Documents

Publication Publication Date Title
AU2016207008B2 (en) Production of rhamnolipid compositions
WO2016115048A1 (fr) Production de compositions à base de rhamnolipides
EP3042940B1 (fr) Composition contenant un sophorolipide à faible toxicité, et utilisation de celui-ci
JP6171229B2 (ja) ソホロリピッドの製造方法および該製造方法により得られたソホロリピッドを含有するソホロリピッド含有組成物
JP2014177633A (ja) 低ステロール且つ高トリグリセライドの微生物性油を得るための極性溶媒によるステロール抽出
WO2019201478A1 (fr) Nouveau procédé pour fournir des compositions d'huile eicosapentaénoïques
AU2018309664B2 (en) Enhanced production of rhamnolipids using at least two carbon sources
CN114164041B (zh) 一种提取高山被孢霉所含油脂的方法
US12589154B2 (en) Acid type sophorolipid-containing composition which is suppressed in browning
JP6521211B2 (ja) セロビオースリピッドを有効成分とする賦活化剤
JP2009013163A (ja) 化粧品添加剤
CN119997928A (zh) 用于使用鼠李糖脂控制痤疮的方法和组合物
JP2026505767A (ja) 創傷治癒のためのラムノリピッド
JP2025043182A (ja) ナガミルエキスの製造方法
JPH06311882A (ja) 海洋性微細藻類の脱臭方法
CN119095944A (zh) 洗净剂组合物
TW201313893A (zh) 使用包含至少五個碳原子及一或二個氧原子之溶劑的液相-液相萃取技術

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16737680

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2973183

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2017555441

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: MX/A/2017/009126

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20177021080

Country of ref document: KR

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2016737680

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2016207008

Country of ref document: AU

Date of ref document: 20160111

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112017014710

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112017014710

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20170707

WWG Wipo information: grant in national office

Ref document number: 2016737680

Country of ref document: EP